Home / Inspections / 776145

FDA Inspection 776145 — Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc.

Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. — FEI 1310337

The FDA completed an inspection of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. on April 6, 2012 in Rouses Point, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rouses Point, NY (United States)

Facility

Other inspections at this facility

  • 1019905 (VAI Thu Jul 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 837463 (VAI Fri Jun 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 736045 (NAI Thu Jul 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 635806 (NAI Thu Dec 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 596461 (NAI Fri Jul 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources